We are live on ! Find out more
TNDM icon

Tandem Diabetes Care
TNDM

46 hedge funds and large institutions have $28M invested in Tandem Diabetes Care in 2017 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 10 increasing their positions, 15 reducing their positions, and 24 closing their positions.

New
Increased
Maintained
Reduced
Closed

90% more capital invested

Capital invested by funds: $14.7M → $28M (+$13.3M)

0.53% less ownership

Funds ownership: 3.69% → 3.16% (-0.53%)

27% less funds holding

Funds holding: 63 → 46 (-17)

33% less repeat investments, than reductions

Existing positions increased: 10 | Existing positions reduced: 15

71% less first-time investments, than exits

New positions opened: 7 | Existing positions closed: 24

Holders
46
Holders Change
-17
Holders Change %
-26.98%
% of All Funds
1.15%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
10
Reduced
15
Closed
24
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$154K
2
SKK
Shepherd Kaplan Krochuk
Massachusetts
+$115K
3
Vanguard Group
Vanguard Group
Pennsylvania
+$107K
4
Jacobs Levy Equity Management
Jacobs Levy Equity Management
New Jersey
+$102K
5
VF
Virtu Financial
New York
+$63K

Top Sellers

Rank Fund Capital Flow
1
DCM
DAFNA Capital Management
California
-$579K
2
PC
Paulson & Co
New York
-$400K
3
Bank of America
Bank of America
North Carolina
-$314K
4
FPC
Falcon Point Capital
California
-$209K
5
RPAM
Rhenman & Partners Asset Management
Sweden
-$187K
Name Holding Trade Value Shares
Change 		Change in
Stake
ARTA
51
A.R.T. Advisors
New York
– -$79K -9,944 Closed
WI
52
WrapManager Inc
California
– -$79K -9,914 Closed
Goldman Sachs
53
Goldman Sachs
New York
– -$79K -9,847 Closed
LP
54
LMR Partners
United Kingdom
– -$74K -9,183 Closed
TRCT
55
Tower Research Capital (TRC)
New York
– -$53K -6,637 Closed
AQR Capital Management
56
AQR Capital Management
Connecticut
– -$49K -6,131 Closed
JMPWA
57
JP Morgan Private Wealth Advisors
California
– -$47K -5,884 Closed
Morgan Stanley
58
Morgan Stanley
New York
– -$30.2K -4,778 -100%
Deutsche Bank
59
Deutsche Bank
Germany
– -$28.2K -4,454 -100%
D.E. Shaw & Co
60
D.E. Shaw & Co
New York
– -$28K -3,477 Closed
Wolverine Trading
61
Wolverine Trading
Illinois
– -$17K -2,079 Closed
LTFS
62
Ladenburg Thalmann Financial Services
Florida
– -$9.95K -1,572 -98%
Barclays
63
Barclays
United Kingdom
– -$11K -1,369 Closed
Squarepoint
64
Squarepoint
New York
– -$9K -1,165 Closed
GI
65
Gradient Investments
Minnesota
– -$3K -400 Closed
EWM
66
Edge Wealth Management
New York
– -$3K -353 Closed
1 2
3

TNDM Hedge Fund Activity: Q3 2017 in Review

46 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Tandem Diabetes Care (TNDM) for Q3 2017, worth a combined $28M — up 90% from $14.7M a quarter earlier.

Sellers outnumbered buyers: 24 funds closed out of TNDM and 7 opened new positions — a net loss of 17 holders — while 15 trimmed existing stakes and 10 added.

The largest buyer was BlackRock, adding an estimated $154K. The largest seller was DAFNA Capital Management, exiting entirely with an estimated $579K sold.

  • 46 institutional investors held Tandem Diabetes Care (TNDM) as of Q3 2017, down from 63 in Q2 2017.
  • Funds reported $28M of Tandem Diabetes Care stock for Q3 2017, up 90% quarter-over-quarter.
  • 7 funds opened new Tandem Diabetes Care positions in Q3 2017 and 24 closed out, a net change of -17 holders.
  • The largest Tandem Diabetes Care buyer in Q3 2017 was BlackRock, an estimated $154K added.
  • The largest Tandem Diabetes Care seller in Q3 2017 was DAFNA Capital Management, an estimated $579K sold.

Based on aggregated 13F filings for Q3 2017.